Carregant...
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Migraine is a very disabling disorder with severe impact on patients’ lives and substantive costs to society in terms of healthcare costs and lost productivity. Prevention is a key component of migraine therapy, and while numerous preventive options exist, each is burdened by either troublesome side...
Guardat en:
| Publicat a: | Curr Treat Options Neurol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486583/ https://ncbi.nlm.nih.gov/pubmed/28653227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11940-017-0463-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|